18F-FDG-PET/CT, 99mTc-MIBI and MRI in the Prediction of Outcome of Patients with Multiple Myeloma(376 views) Fonti R, Pace L, Cerchione C, Catalano L, Pane F, Salvatore M, Del Vecchio S
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 1619-7070print), 2015 Jan 20; 40: 303-308.
From the *Institute of Biostructures and Bioimages, National Research Council, Naples
†Department of Medicine and Surgery, University of Salerno, Salerno
Departments of ‡Hematology, and §Advanced Biomedical Sciences, University of Federico II, Naples, Italy.
daggerDepartment of Medicine and Surgery, University of Salerno, Salerno
Departments of double daggerHematology, and section signAdvanced Biomedical Sciences, University of Federico II, Naples, Italy.
Department of Medicine and Surgery, University of Salerno, Salerno
Departments of Hematology, and Advanced Biomedical Sciences, University of Federico II, Naples, Italy.
References: Not available.
18F-FDG-PET/CT, 99mTc-MIBI and MRI in the Prediction of Outcome of Patients with Multiple Myeloma
PURPOSE: The aim of this study was to compare the relative contribution of F-FDG PET/CT, Tc-MIBI, and MRI in predicting progression-free survival (PFS) and overall survival (OS) in multiple myeloma (MM) patients.
18F-FDG-PET/CT, 99mTc-MIBI and MRI in the Prediction of Outcome of Patients with Multiple Myeloma
Testino G, Leone S, Fagoonee S, Del Bas JM, Rodriguez B, Puiggros F, Marine S, Rodriguez MA, Morina D, Armengol L, Caimari A, Arola L, Cimini FA, Barchetta I, Carotti S, Bertoccini L, Baroni MG, Vespasiani-gentilucci U, Cavallo MG, Morini S, Nelson JE, Roth CL, Wilson LA, Yates KP, Aouizerat B, Morgan-stevenson V, Whalen E, Hoofnagle A, Mason M, Gersuk V, Yeh MM, Kowdley KV, Lee SM, Jun DW, Cho YK, Jang KS, Kucukazman M, Ata N, Dal K, Yeniova AO, Kefeli A, Basyigit S, Aktas B, Akin KO, Agladioglu K, Ure OS, Topal F, Nazligul Y, Beyan E, Ertugrul DT, Catena C, Cosma C, Camozzi V, Plebani M, Ermani M, Sechi LA, Fallo F, Goto Y, Ray MB, Mendenhall CL, French SW, Gartside PS Serum vitamin A deficiency and increased intrahepatic expression of cytokeratin antigen in alcoholic liver disease(731 views) Hepatology (ISSN: 1827-1669electronic, 0026-4806linking), 1988 Sep; 83120693611123109(5): 1019-1026. Impact Factor:0.913 ViewExport to BibTeXExport to EndNote